PURPOSE: To investigate the utility of hyperpolarized He-3 MRI for detecting regional lung ventilated volume (VV) changes in response to exercise challenge and leukotriene inhibitor montelukast, human subjects with exercise induced bronchoconstriction (EIB) were recruited. This condition is described by airway constriction following exercise leading to reduced forced expiratory volume in 1 second (FEV1) coinciding with ventilation defects on hyperpolarized He-3 MRI. MATERIALS AND METHODS:Thirteen EIB subjects underwentspirometry and He-3 MRI at baseline, postexercise, and postrecovery at multiple visits. On one visit montelukast was given and on two visits placebo was given. Regional VV was calculated in the apical/basilar dimension, in the anterior/posterior dimension, and for the entire lung volume. The whole lung VV was used as an end-point and compared with spirometry. RESULTS:Postchallenge FEV1 dropped with placebo but not with treatment, while postchallenge VV dropped more with placebo than treatment. Sources of variability for VV included region (anterior/posterior), scan, and treatment. VV correlated with FEV1/ forced vital capacity (FVC) and forced expiratory flow between 25 and 75% of FVC and showed gravitational dependence after exercise challenge. CONCLUSION: A paradigm testing the response of ventilation to montelukast revealed both a whole-lung and regional response to exercise challenge and therapy in EIB subjects.
RCT Entities:
PURPOSE: To investigate the utility of hyperpolarized He-3 MRI for detecting regional lung ventilated volume (VV) changes in response to exercise challenge and leukotriene inhibitor montelukast, human subjects with exercise induced bronchoconstriction (EIB) were recruited. This condition is described by airway constriction following exercise leading to reduced forced expiratory volume in 1 second (FEV1) coinciding with ventilation defects on hyperpolarized He-3 MRI. MATERIALS AND METHODS: Thirteen EIB subjects underwent spirometry and He-3 MRI at baseline, postexercise, and postrecovery at multiple visits. On one visit montelukast was given and on two visits placebo was given. Regional VV was calculated in the apical/basilar dimension, in the anterior/posterior dimension, and for the entire lung volume. The whole lung VV was used as an end-point and compared with spirometry. RESULTS: Postchallenge FEV1 dropped with placebo but not with treatment, while postchallenge VV dropped more with placebo than treatment. Sources of variability for VV included region (anterior/posterior), scan, and treatment. VV correlated with FEV1/ forced vital capacity (FVC) and forced expiratory flow between 25 and 75% of FVC and showed gravitational dependence after exercise challenge. CONCLUSION: A paradigm testing the response of ventilation to montelukast revealed both a whole-lung and regional response to exercise challenge and therapy in EIB subjects.
Authors: John P Mugler; Talissa A Altes; Iulian C Ruset; Isabel M Dregely; Jaime F Mata; G Wilson Miller; Stephen Ketel; Jeffrey Ketel; F William Hersman; Kai Ruppert Journal: Proc Natl Acad Sci U S A Date: 2010-11-22 Impact factor: 11.205
Authors: Ronald L Sorkness; Eugene R Bleecker; William W Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Douglas Curran-Everett; Serpil C Erzurum; Benjamin M Gaston; Elliot Israel; Nizar N Jarjour; Wendy C Moore; Stephen P Peters; W Gerald Teague; Sally E Wenzel Journal: J Appl Physiol (1985) Date: 2007-11-08
Authors: Neil Woodhouse; Jim M Wild; Martyn N J Paley; Stanislao Fichele; Zead Said; Andrew J Swift; Edwin J R van Beek Journal: J Magn Reson Imaging Date: 2005-04 Impact factor: 4.813
Authors: David J Niles; Stanley J Kruger; Bernard J Dardzinski; Amy Harman; Nizar N Jarjour; Marcella Ruddy; Scott K Nagle; Christopher J François; Sean B Fain Journal: Radiology Date: 2012-11-20 Impact factor: 11.105
Authors: S Sivaram Kaushik; Zackary I Cleveland; Gary P Cofer; Gregory Metz; Denise Beaver; John Nouls; Monica Kraft; William Auffermann; Jan Wolber; H Page McAdams; Bastiaan Driehuys Journal: Magn Reson Med Date: 2010-12-16 Impact factor: 4.668
Authors: Eduard E de Lange; Talissa A Altes; James T Patrie; Jaywant Parmar; James R Brookeman; John P Mugler; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2007-03-13 Impact factor: 10.793
Authors: Eduard E de Lange; Talissa A Altes; James T Patrie; John J Battiston; Adam P Juersivich; John P Mugler; Thomas A Platts-Mills Journal: Radiology Date: 2009-02 Impact factor: 11.105
Authors: Sean B Fain; Guillermo Gonzalez-Fernandez; Eric T Peterson; Michael D Evans; Ronald L Sorkness; Nizar N Jarjour; William W Busse; Janet E Kuhlman Journal: Acad Radiol Date: 2008-06 Impact factor: 3.173
Authors: Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain Journal: Eur J Radiol Date: 2016-09-16 Impact factor: 3.528
Authors: Stanley J Kruger; Scott K Nagle; Marcus J Couch; Yoshiharu Ohno; Mitchell Albert; Sean B Fain Journal: J Magn Reson Imaging Date: 2015-07-27 Impact factor: 4.813
Authors: Wei Zha; Stanley J Kruger; Robert V Cadman; David G Mummy; Michael D Evans; Scott K Nagle; Loren C Denlinger; Nizar N Jarjour; Ronald L Sorkness; Sean B Fain Journal: Acad Radiol Date: 2017-11-23 Impact factor: 3.173
Authors: Wei Zha; Stanley J Kruger; Kevin M Johnson; Robert V Cadman; Laura C Bell; Fang Liu; Andrew D Hahn; Michael D Evans; Scott K Nagle; Sean B Fain Journal: J Magn Reson Imaging Date: 2017-10-31 Impact factor: 4.813
Authors: Ryan C Murphy; Ying Lai; James D Nolin; Robier A Aguillon Prada; Arindam Chakrabarti; Michael V Novotny; Michael C Seeds; William A Altemeier; Michael H Gelb; Robert Duncan Hite; Teal S Hallstrand Journal: Am J Physiol Lung Cell Mol Physiol Date: 2021-02-03 Impact factor: 5.464